Blake M S, Blake C M, Apicella M A, Mandrell R E
Laboratory of Bacteriology and Immunology, Rockefeller University, New York, New York 10021.
Infect Immun. 1995 Apr;63(4):1434-9. doi: 10.1128/iai.63.4.1434-1439.1995.
Previous evidence from our laboratory suggested that the tight intercellular adhesions between the outer membranes of gonococci displaying the opacity colony phenotype occurred because Opa proteins expressed on one gonococcus adhered to the lipooligosaccharide (LOS) of the opposing bacterium (M.S. Blake, p. 51-66, in G. G. Jackson and H. Thomas, ed., The Pathogenesis of Bacterial Infections, 1985, and M. S. Blake and E. C. Gotschlich, p. 377-400, in M. Inouye, ed., Bacterial Outer Membranes as Model Systems, 1986). A noncompetitive inhibition assay used previously to determine the carbohydrate structures recognized by the major hepatic asialoglycoprotein receptor was modified to determine the gonococcal LOS structures that bind Opa proteins (R. T. Lee, Targeted Diagn. Ther. Ser. 4:65-84, 1991). The LOS carbohydrates used in these assays were LOS structures purified from pyocin LOS mutants of Neisseria gonorrhoeae 1291 described by K. C. Dudas and M. A. Apicella (Infect. Immun. 56:499-504, 1988) and further characterized by C. M. John et al. (J. Biol. Chem. 266:19303-19311, 1991). Purified gonococcal Opa proteins were incubated with each of the parent and mutant LOS, and the amount of binding of Opa proteins was measured by a direct enzyme-linked immunosorbent assay using the Opa-specific monoclonal antibody 4B12. The affinities of the Opa proteins for each of the LOS were determined indirectly by measuring the concentrations of Opa proteins that noncompetitively inhibited 50% of the binding of LOS-specific monoclonal antibodies. This concentration is inversely proportional to the affinity of the inhibitor (R. T. Lee, Targeted Diagn. Ther. Ser. 4:65-84, 1991). Our data suggest that the gonococcal Opa proteins tested had the highest affinity for the Gal beta 1-4GlcNAc residue present on the gonococcal lactoneoseries LOS. This affinity was comparable to that reported for the binding of the major hepatic asialoglycoprotein receptor to glycoconjugates containing terminal galactose and N-acetylgalactosamine (R. T. Lee, Targeted Diagn. Ther. Ser. 4:65-84, 1991). After sialylation of the lactoneoseries LOS, presumably on the terminal galactose residue, the interaction with the Opa proteins was ablated. Therefore, the gonococcal Opa-LOS and mammalian epithelial cell asialoglycoprotein receptor-carbohydrate interactions have quite similar specificities.
我们实验室之前的证据表明,表现出不透明菌落表型的淋球菌外膜之间紧密的细胞间黏附的发生,是因为在一个淋球菌上表达的Opa蛋白与相对细菌的脂寡糖(LOS)相结合(M.S. Blake,第51 - 66页,载于G.G. Jackson和H. Thomas编著的《细菌感染的发病机制》,1985年;以及M.S. Blake和E.C. Gotschlich,第377 - 400页,载于M. Inouye编著的《作为模型系统的细菌外膜》,1986年)。之前用于确定主要肝脏去唾液酸糖蛋白受体所识别的碳水化合物结构的非竞争性抑制试验,经修改后用于确定结合Opa蛋白的淋球菌LOS结构(R.T. Lee,《靶向诊断与治疗系列》4:65 - 84,1991年)。这些试验中使用的LOS碳水化合物是从K.C. Dudas和M.A. Apicella描述的淋病奈瑟菌1291的绿脓菌素LOS突变体中纯化得到的LOS结构(《感染与免疫》56:499 - 504,1988年),并由C.M. John等人进一步鉴定(《生物化学杂志》266:19303 - 19311,1991年)。将纯化的淋球菌Opa蛋白与每种亲本和突变体LOS一起孵育,使用Opa特异性单克隆抗体4B12通过直接酶联免疫吸附测定法测量Opa蛋白的结合量。通过测量非竞争性抑制50%的LOS特异性单克隆抗体结合的Opa蛋白浓度,间接确定Opa蛋白对每种LOS的亲和力。该浓度与抑制剂的亲和力成反比(R.T. Lee,《靶向诊断与治疗系列》4:65 - 84,1991年)。我们的数据表明,所测试的淋球菌Opa蛋白对淋球菌内酯系列LOS上存在的Galβ1 - 4GlcNAc残基具有最高亲和力。这种亲和力与报道的主要肝脏去唾液酸糖蛋白受体与含有末端半乳糖和N - 乙酰半乳糖胺的糖缀合物的结合亲和力相当(R.T. Lee,《靶向诊断与治疗系列》4:65 - 84,1991年)。内酯系列LOS在可能是末端半乳糖残基上进行唾液酸化后,与Opa蛋白的相互作用被消除。因此,淋球菌Opa - LOS与哺乳动物上皮细胞去唾液酸糖蛋白受体 - 碳水化合物的相互作用具有非常相似的特异性。